Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia. Cheng F, Li T, Zhang L, Xu M, et al. PLoS One 2026;21:e0347651.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cheng F, Li T, Zhang L, Xu M, et al. Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia. PLoS One 2026;21:e0347651.
PMID: 41996444